Our team is comprised of professional individuals who come from different knowledge areas: molecular and microbiology scientists and senior laboratory technicians, pharmaceutical, biotechnology, veterinary and financial professionals.
Saeid Babaei PhD, MBA President & CEO
Dr. Babaei has over 20 years of academic and corporate experience in the biotechnology sector. Prior to AbCelex, he was the VP of business development at Lorus Therapeutics (now Aptose Biosciences), where he was responsible for product and technology licensing, strategic planning, and investor relations. During his tenure at Lorus, Dr. Babaei was central to the creation and management of the internal portfolio review and prioritization processes. ↓
Prior to Lorus, Saeid served as Director of Corporate Development at Northern Therapeutics where he negotiated and executed a variety of key deal transactions, which included the out-licensing of clinical programs, the in-licensing of research technologies, and the establishment of R&D collaborations. Dr. Babaei has served as President of AngioCell, providing partnering support and advice to a range of clients on licensing, M&A, pipeline valuation, strategic planning and project financing. Dr. Babaei holds a PhD and an executive MBA, both from the University of Toronto. He has authored over 50 publications including research papers, conference presentations, and patents. He currently serves as Chairman of the Board of Directors of BriaCell Therapeutics, a clinical stage immuno-oncology company listed on TSX-V.
Dr. Goldbach is an intellectual property specialist with extensive personal experience in biomedical research. He holds a PhD in Molecular Genetics from the University of Toronto; a law degree (JD) from Osgoode Hall Law School; and was called to the Ontario bar in June of 2014. ↓
The previous year, Phil did his articles with an IP boutique law firm in downtown Toronto where he worked as part of the firm’s life sciences patent practice group. Drawing on both his legal and scientific training, Dr. Goldbach works closely with life science companies, helping them acquire, maintain, and commercialize intellectual property rights as a core aspect of business strategy and development.